AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Bjopan Injection

Prescription Icon
Prescription Required

Marketer

BJ Lifesciences

Salt Composition

Pantoprazole (40mg)

Overview Bjopan Injection

Stomach acid production is reduced by the intravenous medication, Acidulin Injection. It treats stomach and intestinal conditions linked to excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, relieving symptoms and fostering healing. Acidulin Injection also prevents stress ulcers in critically ill patients and is used pre-anesthesia to mitigate aspiration risks. A proton pump inhibitor (PPI), it's administered intravenously by a healthcare provider only when deemed superior to oral forms by your physician. Dosage depends on your condition and response, with treatment duration determined by your doctor; continue as prescribed, even with rapid symptom relief. Dietary modifications—smaller, more frequent meals; avoidance of caffeine, spicy, and fatty foods—can enhance treatment effectiveness. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year or with higher doses, increases bone fracture risk. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Acidulin Injection is unsuitable for individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or breastfeeding individuals should consult their physician. Alcohol should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or drowsiness occurs.

Primary Ingredients of Bjopan Injection

No text provided. Please provide the text you wish to be rewritten.

Uses of Bjopan Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Bjopan Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Bjopan Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Bjopan Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Bjopan Injection works:

Gastric acid production is decreased by Bjopan Injection, a proton pump inhibitor, thereby alleviating heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while using Bjopan Injection.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Bjopan Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Bjopan Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Bjopan Injection's effect on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Bjopan Injection poses no known safety concerns for patients with renal impairment and requires no dosage modification.

LiverLiverCAUTION

For patients with severe hepatic impairment, Bjopan Injection requires careful administration. Dosage modification of Bjopan Injection may be necessary. Physician consultation is advised.

What if you forget to take Bjopan Injection :

Omit a Bjopan Injection dose? Seek your physician's advice.

Facts to Know About Bjopan Injection

LabelValue
Type of Compound Benzimidazole sulfoxide
Potential for Dependence None.
Medication Classification Gastrointestinal tract
Mechanism of Action Gastric acid secretion suppressants

FAQs on Bjopan Injection

Peptic ulcer disease, reflux esophagitis, and gastroesophageal reflux disease (GERD) are all treatable with Bjopan Injection. This injection counteracts the acidity often caused by analgesic use. Furthermore, it's indicated for Zollinger-Ellison syndrome (ZES), a condition characterized by overproduction of stomach acid. Bjopan Injection achieves its therapeutic effect by decreasing gastric acid secretion, thereby alleviating associated symptoms.
Concurrent use of antacids and Bjopan Injection is permissible. Administer antacids at least two hours prior to, or following, Bjopan Injection administration.
Improvement should be noticeable within 2 to 3 days. However, Bjopan Injection may require up to 4 weeks to fully take effect; some symptoms might persist until then.
Prolonged use of Bjopan Injection may, in uncommon instances, lead to increased body weight. This potential side effect might stem from improved reflux symptoms, potentially increasing appetite. Discuss any weight concerns with your physician.
Bjopan Injection should not be taken with alcohol. While alcohol doesn't directly interfere with Bjopan Injection's mechanism, it elevates acid production, potentially exacerbating existing symptoms.
Administer Bjopan Injection one hour prior to eating. Consuming spicy or fatty foods should be avoided during treatment. Refrain from beverages containing caffeine, including tea, coffee, and cola. Alcohol consumption is also discouraged, as it could exacerbate existing symptoms.
Bjopan Injection is typically intended for short-term treatment. Nevertheless, in specific cases like peptic ulcer disease or Zollinger-Ellison syndrome, prolonged administration may be medically necessary. Extended use, however, increases the potential for adverse reactions and requires careful monitoring by a physician. Always adhere to your doctor's instructions and remain under their care while using Bjopan Injection.
Concurrent use of analgesics and Bjopan Injection is safe. Bjopan Injection mitigates the risk of painkiller-induced stomach ulcers and acidity. Bjopan Injection should be administered one hour pre-meal, while analgesics are typically best consumed with or after food to minimize gastrointestinal discomfort.
A single dose of Bjopan Injection may prove inadequate. Relief from symptoms often occurs within a few doses. Treatment with Bjopan Injection is typically short-term, lasting up to two weeks for conditions like heartburn, indigestion, and acid reflux. Longer-term administration may be necessary, however, for conditions such as peptic ulcer disease or Zollinger-Ellison syndrome (ZES), as determined by your physician. If symptoms persist after two weeks of regular use as directed, seek medical advice.
Extended Bjopan Injection use beyond three months can trigger adverse reactions. Low blood magnesium is a primary concern, potentially causing fatigue, confusion, dizziness, tremors, or muscle spasms, and irregular heartbeat. Use exceeding one year elevates the risk of bone fractures, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can lead to anemia, manifesting as fatigue, weakness, pallor, palpitations, dyspnea, lightheadedness, dyspepsia, anorexia, flatulence, or neurological symptoms including numbness, paresthesia, and gait disturbances.
Bjopan Injection
40
MRP 49
18% off